Results 41 to 50 of about 2,289,660 (191)

Transcatheter therapies for tricuspid valve regurgitation

, 2020
: Tricuspid regurgitation, either isolated or associated with left-valve disease, has a strong impact on outcome. Surgical treatment of tricuspid regurgitation has increased in recent years, but in-hospital mortality remains high probably due to the risk
Fiorina C., Metra M., Adamo M., Zaccone G., Di Pasquale M., Curello S.   +5 more
core   +1 more source

Combined Transcatheter Tricuspid and Pulmonary Valve Replacement. [PDF]

, 2020
For patients with combined tricuspid and pulmonary valve disease, operative intervention carries high mortality risk. Published reports of combined transcatheter tricuspid and pulmonary valve replacement have been limited to single cases.A retrospective ...
Small, Adam J, Aksoy, Olcay, Salem, Morris M, Yang, Eric H, Levi, Daniel S, Aboulhosn, Jamil A   +5 more
core   +1 more source

Update on Transcatheter Treatment of Mitral and Tricuspid Valve Regurgitation. [PDF]

, 2023
PURPOSE OF REVIEW Mitral and tricuspid regurgitation represents a clinical challenge. They are associated with a poor prognosis, and many patients are not eligible for conventional surgery.
Boone, R.H., Muller, Olivier, Praz, F., Blanke, P., Sathananthan, J., Meier, David, Praz, Fabien, Cheung, A., Tzimas, Georgios, Webb, J.G., Boone, Robert H, Webb, John G, Akodad, Mariama, Tzimas, G., Meier, D., Wood, D.A., Blanke, Philipp, Cheung, Anson, Wood, David A, Akodad, M., Muller, O., Sathananthan, Janarthanan   +21 more
core   +1 more source

Advances in transcatheter mitral and tricuspid therapies

BMC Cardiovascular Disorders, 2020
Background While rheumatic mitral stenosis has been effectively treated percutaneously for more than 20 years, mitral and tricuspid regurgitation treatment appear as a contemporary unmet need.
Pavel Overtchouk, Nicolo Piazza, Juan Granada, Osama Soliman, Bernard Prendergast, Thomas Modine   +5 more
doaj   +1 more source

Epiphenomenon or Prognostically Relevant Interventional Target? A Novel Proportionality Framework for Severe Tricuspid Regurgitation

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background Tricuspid regurgitation (TR) frequently develops in patients with long‐standing pulmonary hypertension, and both pathologies are associated with increased morbidity and mortality.
Vera Fortmeier, Mark Lachmann, Matthias Unterhuber, Lukas Stolz, Mohammad Kassar, Laurin Ochs, Muhammed Gerçek, Anne R. Schöber, Thomas J. Stocker, Hazem Omran, Maria I. Körber, Amelie Hesse, Kai Peter Friedrichs, Shinsuke Yuasa, Tanja K. Rudolph, Michael Joner, Roman Pfister, Stephan Baldus, Karl‐Ludwig Laugwitz, Fabien Praz, Stephan Windecker, Jörg Hausleiter, Philipp Lurz, Volker Rudolph   +23 more
doaj   +1 more source

Indications, limitations, and development of tricuspid valve interventions in adults

, 2022
Tricuspid regurgitation is associated with excessive mortality and poor outcomes regardless of the cause and associated comorbidities. Despite this clear association with mortality, tricuspid valve diseases remain undertreated.
Ibrahim, Reda, Kresoja, Karl-Patrik, Perrin, Nils, Lurz, Philipp, Modine, Thomas, Ruf, Tobias, Bouhout, Ismail, Fam, Neil, Ben Ali, Walid, Stephan von Bardeleben, Ralph   +9 more
core   +1 more source

Transcatheter Tricuspid Valve-in-Valve Replacement Using a J-Valve System for a Failed Tricuspid Bioprosthesis

, 2022
BACKGROUND: Redo operation for failed tricuspid bioprosthetic valves is associated with high morbidity and mortality. Transcatheter tricuspid valve-in-valve implantation has become an acceptable option for high-risk patients with a failed tricuspid ...
Miao, Lifu, Tang, Xiujie, Zhang, Mingkui, Xue, Hui, Xiujie Tang, Lifu Miao, Hui Xue, Yanbin Shao, Shao, Yanbin, Mingkui Zhang   +9 more
core   +1 more source

Future Perspectives in Percutaneous Treatment of Tricuspid Regurgitation

Frontiers in Cardiovascular Medicine, 2020
Tricuspid regurgitation (TR) has a not negligible prevalence and its severity is correlated with poorer outcomes. However, surgical options are rarely offered to these patients because of their high surgical risk.
Antonio Mangieri, Matteo Pagnesi, Damiano Regazzoli, Alessandra Laricchia, Edwin Ho, Ythan Goldberg, Mei Chau, Francesco Gallo, Andrea Fisicaro, Arif Khokhar, Antonio Colombo, Francesco Giannini, Azeem Latib   +12 more
doaj   +1 more source

Transcatheter Intervention Is Associated With Visceral Decongestion in Patients With Severe Tricuspid Regurgitation. [PDF]

Clin Cardiol
Patients with severe symptomatic tricuspid regurgitation were assigned to transcatheter tricuspid valve intervention. Most patients showed discontinuous renal vein blood flow (arrows, Grade IV°) prior to TTVI (baseline). At follow‐up after 1 to 3 months, patients showed continuous renal vein blood flow profile (arrows, Grade I°) representing a marked ...
Putz FJ, Spahn J, Kranert PC, Grewe F, Haus M, Wester M, Bienert V, Trum M, Schach C, Luchner A, Birner C, Unsöld B, Banas MC, Banas B, Maier LS, Debl K, Paulus M, Meindl C.   +17 more
europepmc   +2 more sources

Exercise testing in patients with tricuspid regurgitation undergoing transcatheter tricuspid valve intervention. [PDF]

Clin Res Cardiol
Abstract Background Transcatheter tricuspid valve intervention (TTVI) has shown promising results with persistent reduction of tricuspid regurgitation (TR) and improvements in functional class and quality of life (QOL).
Gerçek M, Ivannikova M, Goncharov A, Gerçek M, Mörsdorf M, Kirchner J, Rudolph F, Rudolph TK, Rudolph V, Friedrichs KP, Dumitrescu D.   +10 more
europepmc   +5 more sources